TipRanks Black Friday Sale
- Claim 60% off TipRanks Premium for the data-backed insights and research tools you need to invest with confidence.
- Subscribe to TipRanks' Smart Investor Picks and see our data in action through our high-performing model portfolio - now also 60% off
An announcement from Genor Biopharma Holdings Limited ( (HK:6998) ) is now available.
Genor Biopharma Holdings Limited has announced a board meeting scheduled for August 27, 2025, to review and approve the interim financial results for the first half of the year. This meeting is crucial for stakeholders as it will provide insights into the company’s financial health and operational performance, potentially impacting its market positioning and investor confidence.
More about Genor Biopharma Holdings Limited
Genor Biopharma Holdings Limited is a company incorporated in the Cayman Islands, operating in the biopharmaceutical industry. It focuses on the development and commercialization of innovative therapeutic products, with a market presence in Hong Kong.
Average Trading Volume: 1,528,998
Technical Sentiment Signal: Buy
Current Market Cap: HK$1.79B
See more insights into 6998 stock on TipRanks’ Stock Analysis page.